Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers
Julien Dufort‐Gervais(Hôpital du Sacré-Cœur de Montréal), Jonathan Brouillette(Inserm)
Cited by 50
Related Papers
Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
|Journal of Neuroscience|2012|171
Hippocampal injections of soluble amyloid-beta oligomers alter electroencephalographic activity during wake and slow-wave sleep in rats
|Alzheimer s Research & Therapy|2023|13